Glucagon-like peptide 1 (GLP-1)

• Main Authors: T.D. Müller (Author), B. Finan (Author), S.R. Bloom (Author), D. D'Alessio (Author), D.J. Drucker (Author), P.R. Flatt (Author), A. Fritsche (Author), F. Gribble (Author), H.J. Grill (Author), J.F. Habener (Author), J.J. Holst (Author), W. Langhans (Author), J.J. Meier (Author), M.A. Nauck (Author), D. Perez-Tilve (Author), A. Pocai (Author), F. Reimann (Author), D.A. Sandoval (Author), T.W. Schwartz (Author), R.J. Seeley (Author), K. Stemmer (Author), M. Tang-Christensen (Author), S.C. Woods (Author), R.D. DiMarchi (Author), M.H. Tschöp (Author)
• Format: Book
• Published: Elsevier, 2019-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: The glucagon-like peptide-1 (GLP-1) is a multifaceted hormone with broad pharmacological potential. Among the numerous metabolic effects of GLP-1 are the glucose-dependent stimulation of insulin secretion, decrease of gastric emptying, inhibition of food intake, increase of natriuresis a...